Niall O'Donnell - May 8, 2023 Form 4 Insider Report for Reneo Pharmaceuticals, Inc. (RPHM)

Role
Director
Signature
/s/ Jennifer P. Lam, Attorney-in-Fact
Stock symbol
RPHM
Transactions as of
May 8, 2023
Transactions value $
$1,000,000
Form type
4
Date filed
5/10/2023, 05:47 PM
Previous filing
May 16, 2023
Next filing
May 26, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RPHM Common Stock Purchase $1M +125K +6.06% $8.00 2.19M May 8, 2023 By RiverVest Venture Fund IV, L.P. F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares were purchased in the Issuer's public offering.
F2 The shares held by RiverVest Venture Fund IV, L.P. ("RiverVest Fund IV") are indirectly held by RiverVest Venture Partners IV, L.P., its general partner ("RiverVest Partners IV"). RiverVest Venture Partners IV, LLC is the general partner of RiverVest Partners IV. The individual managers of RiverVest Ventures Partners IV, LLC are Jay Schmelter, John P. McKearn, Ph.D. and the Reporting Person. RiverVest Partners IV, RiverVest Venture Partners IV, LLC and each of the individual managers (including the Reporting Person) share voting and dispositive power with regard to the Company's securities directly held by RiverVest Fund IV.